Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Cyclocreatine phosphate is an anti-tumor agent. Cyclocreatine phosphate(CCrP) is the proposed active form of cyclocreatine (CCr), a substrate analogue of creatine kinase. Cyclocreatine and its water-soluble derivative, cyclocreatine phosphate (CCrP), are potent cardioprotective drugs. Cyclocreatine phosphate can be used for the research of cancer[1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | Inquiry | |
50 mg | 6-8 weeks | Inquiry | |
100 mg | 6-8 weeks | Inquiry |
Description | Cyclocreatine phosphate is an anti-tumor agent. Cyclocreatine phosphate(CCrP) is the proposed active form of cyclocreatine (CCr), a substrate analogue of creatine kinase. Cyclocreatine and its water-soluble derivative, cyclocreatine phosphate (CCrP), are potent cardioprotective drugs. Cyclocreatine phosphate can be used for the research of cancer[1]. |
In vivo | Cyclocreatine phosphate (CCrP), administered intraperitoneally (i.p.) at a concentration of 37.5 mg/mL and a dosage of 0.2 mL twice daily, demonstrated anti-tumor activity in athymic (CD1-Nu/Nu) male mice within a human prostate cancer xenograft model, without eliciting significant toxicity signs [1]. |
Molecular Weight | 223.12 |
Formula | C5H10N3O5P |
CAS No. | 61839-19-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Cyclocreatine phosphate 61839-19-8 inhibitor inhibit